(Adnkronos) – Laura Calabresi, full professor of pharmacology at the Department of Pharmacological and Biomolecular Sciences of the University of Milan, spoke at the presentation of the results of the Racers study, with which Abionyx Pharma, a new generation biotech company dedicated to the discovery and development of innovative therapies, it wanted to evaluate the efficacy of the new and innovative drug Cer-001 in the treatment of acute sepsis. Here are her words.
#Calabresi #Hdl #sepsis #covid #cardiovascular #diseases
Chip in the brain “is the future”, the head doctor at San Raffaele promotes Musk
"It's the future." Pietro Mortini, head of neurosurgery at the IRCCS San Raffaele hospital in Milan and full professor of...
